company background image
301096 logo

Hangzhou Bio-Sincerity Pharma-TechLtd SZSE:301096 Stock Report

Last Price

CN¥40.02

Market Cap

CN¥4.3b

7D

0%

1Y

-39.5%

Updated

25 Nov, 2024

Data

Company Financials +

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.

SZSE:301096 Stock Report

Market Cap: CN¥4.3b

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hangzhou Bio-Sincerity Pharma-TechLtd
Historical stock prices
Current Share PriceCN¥40.02
52 Week HighCN¥77.78
52 Week LowCN¥33.57
Beta0.31
11 Month Change-10.53%
3 Month Change12.76%
1 Year Change-39.46%
33 Year Changen/a
5 Year Changen/a
Change since IPO-60.41%

Recent News & Updates

We Believe That Hangzhou Bio-Sincerity Pharma-TechLtd's (SZSE:301096) Weak Earnings Are A Good Indicator Of Underlying Profitability

Nov 04
We Believe That Hangzhou Bio-Sincerity Pharma-TechLtd's (SZSE:301096) Weak Earnings Are A Good Indicator Of Underlying Profitability

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SZSE:301096) Soars 30% But It's A Story Of Risk Vs Reward

Sep 30
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SZSE:301096) Soars 30% But It's A Story Of Risk Vs Reward

Recent updates

We Believe That Hangzhou Bio-Sincerity Pharma-TechLtd's (SZSE:301096) Weak Earnings Are A Good Indicator Of Underlying Profitability

Nov 04
We Believe That Hangzhou Bio-Sincerity Pharma-TechLtd's (SZSE:301096) Weak Earnings Are A Good Indicator Of Underlying Profitability

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SZSE:301096) Soars 30% But It's A Story Of Risk Vs Reward

Sep 30
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SZSE:301096) Soars 30% But It's A Story Of Risk Vs Reward

Market Cool On Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s (SZSE:301096) Earnings Pushing Shares 27% Lower

Jul 24
Market Cool On Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s (SZSE:301096) Earnings Pushing Shares 27% Lower

Solid Earnings May Not Tell The Whole Story For Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096)

Apr 29
Solid Earnings May Not Tell The Whole Story For Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096)

Should You Be Adding Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096) To Your Watchlist Today?

Mar 14
Should You Be Adding Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096) To Your Watchlist Today?

Shareholder Returns

301096CN Life SciencesCN Market
7D0%-4.4%-2.1%
1Y-39.5%-32.3%2.8%

Return vs Industry: 301096 underperformed the CN Life Sciences industry which returned -32.3% over the past year.

Return vs Market: 301096 underperformed the CN Market which returned 2.8% over the past year.

Price Volatility

Is 301096's price volatile compared to industry and market?
301096 volatility
301096 Average Weekly Movement9.9%
Life Sciences Industry Average Movement10.6%
Market Average Movement8.4%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 301096 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 301096's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20111,786Jinfang Louwww.hzbio-s.com

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. operates as a pharmaceutical technology research and development and services company in China. The company primarily provides drug research and development services; and the transformation of research and development technology results for various pharmaceutical, as well as pharmaceutical research and development investment companies.

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Fundamentals Summary

How do Hangzhou Bio-Sincerity Pharma-TechLtd's earnings and revenue compare to its market cap?
301096 fundamental statistics
Market capCN¥4.30b
Earnings (TTM)CN¥212.13m
Revenue (TTM)CN¥1.03b

20.5x

P/E Ratio

4.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
301096 income statement (TTM)
RevenueCN¥1.03b
Cost of RevenueCN¥399.02m
Gross ProfitCN¥626.10m
Other ExpensesCN¥413.96m
EarningsCN¥212.13m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.96
Gross Margin61.08%
Net Profit Margin20.69%
Debt/Equity Ratio21.6%

How did 301096 perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

15%

Payout Ratio